3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Biliary Duct or Gallbladder Cancer

This study is ongoing, but not recruiting participants.

Study NCT00075504 Information provided by National Cancer Institute (NCI)

First Received: January 9, 2004 Last Updated: July 23, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	August 2005 (Final data collection date for primary outcome measure)